Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background Primary Biliary Cholangitis (PBC, formerly cirrhosis), is a chronic cholestatic liver disease which until spring 2016 had a single licensed therapy, Ursodeoxycholic acid (UDCA). Approximately 30% of patients do not respond to UDCA, and are high-risk for progressing to end stage liver disease, transplantation or death. A new era of stratified medicine with second-line therapies to treat high-risk disease is emerging, with the first such second-line agent obeticholic acid recently receiving FDA and EMA approval and entering practice. Recent experience in the USA of inappropriate use and associated deaths has highlighted concerns as to whether clinicians have the knowledge to implement second-line therapies appropriately and safely. Methods Online survey of knowledge regarding optimal PBC management in Gastroenterologists and Hepatologists in the USA; the first 100 completed responses from each group used for analysis. Results 80% of Hepatologists felt they were highly competent in their understanding of the importance of early diagnosis and early UDCA therapy in PBC compared with 65% of gastroenterologists. However, only 36% of Hepatologists and 30% of gastroenterologists felt competent at assessing response to UDCA. Competence in knowledge (mode of action, efficacy, and side effects) of second-line therapies and enrollment into trials was low among both groups. Conclusion Significant knowledge gaps in clinicians managing PBC presents a problem in optimizing care. It…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Poor clinician awareness and understanding of the inherently complex, multi-stage step-up approach, which requires several decision points and multiple follow-up appointments, is a major contributing factor.31”
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citation(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Carbone, M., Mells, G. F., Pells, G., Dawwas, M. F., Newton, J. L., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.005 · Cited by 386
Self-citationEpidemiology and natural history of primary biliary cirrhosis in a U.S. community
Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., Yawn, B. P., Petz, J. L., Melton, L. J., & Dickson, E. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.20197 · Cited by 349
Hirschfield, G. M., & Heathcote, E. J. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch32 · Cited by 261
Honda, A., Ikegami, T., Nakamuta, M., Miyazaki, T., Iwamoto, J., Hirayama, T., Saito, Y., Takikawa, H., Imawari, M., & Matsuzaki, Y. (2013) · Hepatology · doi:10.1002/hep.26018 · Cited by 210
Cited by
Hegade, V. S., Mells, G. F., Fisher, H., Kendrick, S., DiBello, J., Gilchrist, K., Alexander, G. J., Hirschfield, G. M., Sandford, R. N., & Jones, D. E. J. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.007 · Cited by 88
Self-citationJones, D. E. J., Wetten, A., Barron-Millar, B., Ogle, L., Mells, G., Flack, S., Sandford, R., Kirby, J., Palmer, J., Brotherston, S., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104068 · Cited by 22
Self-citationPatient ownership of primary biliary cholangitis long-term management
Leighton, J., Thain, C., Mitchell-Thain, R., Dyson, J. K., & Jones, D. E. J. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101324 · Cited by 8
Self-citationWerner, E., van Hooff, M. C., Weijsters, G. H. X., van de Vrie, M. A., de Veer, R. C., Beuers, U. H., Drenth, J. P. H., Cuperus, F. J. C., van Dijk, R., Veldt, B. J., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70669 · Cited by 3
“These results contribute to previous studies in the UK and the US which showed that dedicated hepatologists felt more competent in their understanding of PBC management compared to general gastroenterologists [14, 29].”
Liu, Y. S., Jia, G., Ding, D. W., Zheng, L. H., Sun, R. Q., Wang, X. F., Deng, J., Yang, C. M., Cui, L. N., Guo, C. C., et al. (2024) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13254 · Cited by 4
Metadata
- Authors
- Jopson, L., Khanna, A., Peterson, P., Rudell, E., Corrigan, M., & Jones, D.
- Affiliations
- Newcastle University (GB)
- University of Birmingham (GB)
- Corresponding author
- Jones, David
- Venue
- Digestive Diseases and Sciences
- Published
- 2018-05-08
- Volume
- 63
- Issue
- 10
- Pages
- 2547-2554
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2801516872
- Cited by
- 9
- References
- 22
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2018: 2
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Projects in Knowledge
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- primary biliary cirrhosis, stratified medicine, obeticholic acid, ursodeoxycholic acid, second-line therapy, clinician knowledge, treatment response assessment, inappropriate medication use, hepatologists, gastroenterologists, clinical competence, disease progression
- MeSH terms
- Gastroenterologists, Chenodeoxycholic Acid, Cholagogues and Choleretics, Clinical Competence, Humans, Liver Cirrhosis, Biliary, Risk Factors, Ursodeoxycholic Acid, Disease Progression, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness. https://app.cochat.ai/papers/10.1007/s10620-018-5074-8
- The paper
- Jopson, L., Khanna, A., Peterson, P., Rudell, E., Corrigan, M., & Jones, D. (2018). Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-018-5074-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.